$0.97 Earnings Per Share Expected for Mylan NV (MYL) This Quarter

Wall Street analysts forecast that Mylan NV (NASDAQ:MYL) will post earnings per share of $0.97 for the current quarter, Zacks reports. Five analysts have made estimates for Mylan’s earnings, with the highest EPS estimate coming in at $1.08 and the lowest estimate coming in at $0.88. Mylan posted earnings of $1.07 per share during the same quarter last year, which suggests a negative year over year growth rate of 9.3%. The firm is scheduled to report its next earnings report on Wednesday, August 14th.

According to Zacks, analysts expect that Mylan will report full year earnings of $4.28 per share for the current year, with EPS estimates ranging from $4.03 to $4.46. For the next fiscal year, analysts forecast that the firm will post earnings of $4.56 per share, with EPS estimates ranging from $4.29 to $4.92. Zacks Investment Research’s EPS averages are an average based on a survey of research firms that that provide coverage for Mylan.

Mylan (NASDAQ:MYL) last released its earnings results on Tuesday, May 7th. The company reported $0.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.79 by $0.03. The business had revenue of $2.50 billion for the quarter, compared to the consensus estimate of $2.70 billion. Mylan had a return on equity of 18.96% and a net margin of 2.14%. Mylan’s quarterly revenue was down 7.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.96 earnings per share.

A number of equities analysts have weighed in on MYL shares. Credit Suisse Group reissued a “buy” rating and set a $37.00 price target on shares of Mylan in a research report on Wednesday, March 6th. Morgan Stanley raised Mylan from an “equal weight” rating to an “overweight” rating and set a $35.00 price target on the stock in a research report on Wednesday, March 6th. They noted that the move was a valuation call. SunTrust Banks started coverage on Mylan in a research report on Tuesday, March 19th. They set a “buy” rating and a $35.00 price target on the stock. BMO Capital Markets boosted their price target on Mylan to $40.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 27th. They noted that the move was a valuation call. Finally, UBS Group reissued a “neutral” rating and set a $31.00 price target on shares of Mylan in a research report on Thursday, March 7th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and fourteen have issued a buy rating to the company. Mylan has an average rating of “Buy” and an average target price of $36.95.

Several hedge funds have recently modified their holdings of MYL. Norges Bank bought a new stake in Mylan during the fourth quarter worth $169,463,000. Oregon Public Employees Retirement Fund lifted its stake in Mylan by 2,715.0% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,145,628 shares of the company’s stock worth $224,000 after purchasing an additional 5,927,314 shares during the last quarter. AQR Capital Management LLC lifted its stake in Mylan by 46.1% during the first quarter. AQR Capital Management LLC now owns 10,136,218 shares of the company’s stock worth $287,261,000 after purchasing an additional 3,198,028 shares during the last quarter. Viking Global Investors LP lifted its stake in Mylan by 85.7% during the first quarter. Viking Global Investors LP now owns 3,583,269 shares of the company’s stock worth $101,550,000 after purchasing an additional 1,653,301 shares during the last quarter. Finally, State of New Jersey Common Pension Fund D lifted its stake in Mylan by 194.0% during the first quarter. State of New Jersey Common Pension Fund D now owns 1,700,000 shares of the company’s stock worth $48,178,000 after purchasing an additional 1,121,745 shares during the last quarter. Institutional investors and hedge funds own 83.79% of the company’s stock.

NASDAQ:MYL opened at $17.40 on Friday. The company has a debt-to-equity ratio of 1.20, a quick ratio of 0.85 and a current ratio of 1.51. The stock has a market capitalization of $9.16 billion, a P/E ratio of 3.80, a P/E/G ratio of 0.92 and a beta of 1.73. Mylan has a 52-week low of $16.63 and a 52-week high of $42.50.

Mylan Company Profile

Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded-generic, brand-name, and over-the-counter (OTC) pharmaceutical products in North America, Europe, and internationally. It offers active pharmaceutical ingredients and finished dosage forms; and antiretroviral medicines to treat HIV/AIDS.

Recommended Story: How Do You Make Money With Penny Stocks?

Get a free copy of the Zacks research report on Mylan (MYL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Mylan (NASDAQ:MYL)

Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.